SiteOne Landscape Supply Inc. reported lower-than-expected earnings for Q2 2025, but reaffirmed its full-year 2025 outlook, citing confidence in its long-term strategy.

Eli Lilly has acquired SiteOne Therapeutics for up to $1 billion to bolster its pain management portfolio and expand its non-opioid treatment options.

SiteOne Landscape Supply Inc. is set to release its Q1 2025 earnings on April 30, 2025, with analysts projecting a slight decrease in earnings per share and a 3.09% increase in revenue.